Northside Hospital, Inc.

Intrathecal Chemoprophylaxis to Prevent Neurotoxicity Associated With Blinatumomab Therapy for Acute Lymphoblastic Leukemia

Role: lead

CAR T-cell Therapy in Patients With Renal Dysfunction

Role: lead

Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia

Role: lead

Belumosudil and Rituximab for Primary Treatment of Chronic Graft-Versus-Host-Disease

Role: lead

GM-CSF With Post-Transplant Cyclophosphamide

Role: lead

Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation

Role: lead

Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant Cyclophosphamide

Role: lead

Ibrutinib and Rituxan for Chronic GVHD

Role: lead

Adding Venetoclax to the High-dose Chemotherapy Regimen Prior to Mismatche Allogeneic Stem Cell Transplant

Role: lead

Lymphodepletion and Anti-PD-1 Blockade to Reduce Relapse in AML Patient Not Eligible for Transplant

Role: lead

Pulmonary Embolism Response to Fragmentation, Embolectomy, & Catheter Thrombolysis: PERFECT

Role: collaborator

High Dose Chemotherapy Using BeEAM for Autologous Transplant in Multiple Myeloma

Role: lead

Reduced Intensity Conditioning Transplant Using Haploidentical Donors

Role: lead

Use of Convalescent Plasma for COVID-19

Role: lead

Nonmyeloablative Haploidentical Transplant Followed by MLN9708

Role: lead

Caregiver Burden and Distress in Hematopoeitic Stem Cell Transplant

Role: lead

MOSTEGRA TRIAL:MO-(Dified) STE-(nt) GRA(-ft): Surgeon-modified Fenestrated-branched Stent-grafts

Role: lead

FOB in HSCT and Leukemia Patients With Acute Respiratory Symptoms and Pulmonary Infiltrates

Role: lead

Palonosetron, Ondansetron, and Dexamethasone for Delayed Nausea and Vomiting in Autologous Transplant Patients

Role: lead

Rituximab for the Primary Treatment of Denovo Extensive Chronic Graft Versus Host Disease (GVHD)

Role: lead